Document is current
Any future updates will be listed below
-
Authors
Brindani, Nicoletta
La Serra, Maria Antonietta
Ortega, Jose Antonio
Arencibia, Jose M.
Nigro, Michela
Bertozzi, Sine Mandrup
Armirotti, Andrea
Borgogno, Marco
Sissi, Claudia
De Vivo, Marco
-
Funding
Funding for this research was provided by:
European Union-Next GenerationEU (PNRR M4C2-Investimento 1.4- CN00000041)
Fondazione AIRC per la ricerca sul cancro ETS (IG 30631)
NextGenerationEU PNRR MUR – M4C2 – Action 1.4, National Center for Gene Therapy and Drug based on RNA Technology (CN00000041)
- License Information
-
More Information
Article History
Received: 2 April 2025
Accepted: 28 May 2025
First Online: 4 June 2025
Declarations
:
: The authors declare the following competing financial interest(s): M.D.V., J.A.O, J.M.A, and C.S. are coinventors on patent related to this work (WO2018/114700Al). All other authors declare no competing interests.
